US Healthcare Costs Average 25 Times Higher for Hemophilia B

US Healthcare Costs Average 25 Times Higher for Hemophilia B

292845

US Healthcare Costs Average 25 Times Higher for Hemophilia B

Healthcare costs can be 25 times higher for hemophilia B patients than for individuals who do not have a bleeding disorder, according to a recent study. These findings reflect both direct costs of hemophilia treatment and a greater need for other healthcare resources, researchers noted. The study, “Health care resource utilization and cost burden of hemophilia B in the United States,” was published in the journal Blood Advances. Although hemophilia B is a rare disorder,…

You must be logged in to read/download the full post.